Details for: RPL23P6

Gene ID: 646949

Gene Type:  Pseudogene  - A non-functional segment of DNA that resembles a functional gene but has lost its protein-coding ability or is otherwise no longer expressed.

Symbol: RPL23P6

Ensembl ID: ENSG00000180211

Description: ribosomal protein L23 pseudogene 6

Cell Significance Landscape

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • CD4-positive, alpha-beta thymocyte CL0000810
    CSI 8.02
    rCSI 6.42%
    PRS 99.32

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.
Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [RPL23P6](/details-gene/646949) is a pseudogene located on chromosome 6p21.2, identified as a non-functional copy of the gene encoding ribosomal protein L23. While pseudogenes are often considered non-coding, some can possess regulatory functions. Expression data indicates that [RPL23P6](/details-gene/646949) has a notable expression significance within [CD4-positive, alpha-beta thymocytes](/details-cell/CL0000810), suggesting a potential, albeit currently uncharacterized, role in T-cell development. ## Cellular Roles and Expression Landscape The available expression data is limited but points to a specific cellular context for [RPL23P6](/details-gene/646949). **Overall**, the gene demonstrates its highest significance in [CD4-positive, alpha-beta thymocytes](/details-cell/CL0000810) (CSI: 8.02). This cell type is a critical intermediate stage in T-lymphocyte maturation within the thymus. The specific expression in these precursor cells may suggest a role during T-cell lineage commitment or selection. A comprehensive analysis of its expression landscape is hindered by the lack of data for other cell types, which would be necessary to determine its specificity and rule out broader expression patterns. ## Pathways and Molecular Function No specific Gene Ontology (GO) or Reactome pathway annotations are available for [RPL23P6](/details-gene/646949). As a pseudogene derived from a ribosomal protein gene, it is not expected to be translated into a functional protein involved in ribosome biogenesis or translation. However, expressed pseudogenes can function as non-coding RNAs. Potential functions include acting as microRNA sponges or competing endogenous RNAs (ceRNAs) that sequester microRNAs, thereby regulating the expression of their parent gene (*RPL23*) or other related targets. ## Research Directions The specific expression of [RPL23P6](/details-gene/646949) in thymocytes, despite it being a pseudogene, warrants further investigation into its potential regulatory functions in T-cell biology. The absence of cross-contextual data (e.g., in disease states) currently limits the ability to assess its role in pathology. **Testable Hypotheses:** 1. [RPL23P6](/details-gene/646949) functions as a long non-coding RNA (lncRNA) that regulates the expression of its parent gene, *RPL23*, or other genes critical for T-cell development through a ceRNA mechanism, titrating microRNAs involved in thymocyte differentiation. 2. The transcript of [RPL23P6](/details-gene/646949) acts as a scaffold, binding to chromatin-modifying enzymes to guide them to specific genomic loci, thereby modulating the epigenetic landscape required for the maturation of [CD4-positive, alpha-beta thymocytes](/details-cell/CL0000810). **Key Experimental Approach:** To test the hypothesis that [RPL23P6](/details-gene/646949) acts as a regulatory lncRNA in T-cell development (Hypothesis 1), one could perform a targeted knockdown of the [RPL23P6](/details-gene/646949) transcript in a human thymocyte cell line or primary CD4+ thymocytes using antisense oligonucleotides (ASOs) or a CRISPR interference (CRISPRi) system. The impact of the knockdown would be assessed via RNA-sequencing to identify genome-wide transcriptional changes, with a specific focus on the parent gene *RPL23* and key T-cell developmental markers. Concurrently, an RNA pull-down assay using biotinylated [RPL23P6](/details-gene/646949) probes followed by mass spectrometry or sequencing could identify its interacting proteins and microRNAs, respectively, validating its proposed mechanism of action. **Therapeutic Potential:** The therapeutic potential of [RPL23P6](/details-gene/646949) is highly speculative at this stage. If future research demonstrates that it is a crucial regulator of T-cell maturation and is aberrantly expressed in T-cell malignancies, such as T-cell acute lymphoblastic leukemia (T-ALL), it could emerge as a novel therapeutic target. In such a scenario, targeting its transcript with ASOs could be a viable strategy to modulate T-cell proliferation or differentiation. However, a thorough understanding of its function and specificity is a prerequisite for any therapeutic consideration.